CIBC Asset Management Inc lifted its position in Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 7.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 3,107 shares of the medical instruments supplier’s stock after buying an additional 224 shares during the period. CIBC Asset Management Inc’s holdings in Mettler-Toledo International were worth $4,660,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the company. Family Firm Inc. bought a new position in Mettler-Toledo International during the 2nd quarter worth about $25,000. Blue Trust Inc. increased its holdings in Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in Mettler-Toledo International during the 3rd quarter worth about $37,000. Rothschild Investment LLC bought a new position in Mettler-Toledo International during the 2nd quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in Mettler-Toledo International during the 2nd quarter worth about $42,000. Institutional investors own 95.07% of the company’s stock.
Insiders Place Their Bets
In other news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.94% of the company’s stock.
Mettler-Toledo International Trading Down 4.7 %
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Analysts forecast that Mettler-Toledo International Inc. will post 40.39 EPS for the current year.
Analysts Set New Price Targets
A number of equities analysts have issued reports on MTD shares. JPMorgan Chase & Co. increased their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Finally, Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $1,338.75.
Check Out Our Latest Analysis on MTD
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories
- Five stocks we like better than Mettler-Toledo International
- What is a support level?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Canadian Penny Stocks: Can They Make You Rich?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.